Ultragenyx Company Insiders
| RARE Stock | USD 20.52 2.98 12.68% |
About 87 percent of Ultragenyx's insiders are activelly selling. The analysis of the overall insider sentiment regarding Ultragenyx suggests that quite a large number of insiders are panicking. Ultragenyx employs about 1.3 K people. The company is managed by 20 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 64.7 employees per reported executive.
| Erik Harris President Executive Vice President and Chief Commercial Officer |
Insider Sentiment 13
Mostly Selling
Selling | Buying |
Latest Trades
| 2026-02-02 | Howard Horn | Disposed 3061 @ 23.56 | View | ||
| 2025-12-29 | Theodore Alan Huizenga | Disposed 85 @ 34.38 | View | ||
| 2025-12-10 | Howard Horn | Disposed 3081 @ 36.38 | View | ||
| 2025-10-13 | Howard Horn | Disposed 7942 @ 31.51 | View | ||
| 2025-09-18 | Theodore Alan Huizenga | Disposed 64 @ 29.17 | View | ||
| 2025-09-12 | Karah Herdman Parschauer | Disposed 2450 @ 31.17 | View | ||
| 2025-08-08 | Gilbert Ray Cisneros, Jr. | Acquired @ 27.54 | |||
| 2025-07-15 | Gilbert Ray Cisneros, Jr. | Acquired @ 27.2 | |||
| 2025-06-20 | Corazon (Corsee) D Sanders | Disposed 2405 @ 37.39 | View | ||
| 2025-05-05 | Eric Crombez | Disposed 520 @ 39.24 | View | ||
| 2025-04-21 | Eric Crombez | Disposed 242 @ 35.11 | View | ||
| 2025-03-06 | Howard Horn | Disposed 1785 @ 40.4 | View | ||
| 2025-03-03 | Thomas Richard Kassberg | Disposed 6028 @ 42.1 | View | ||
| 2025-02-28 | Emil D Kakkis | Disposed 25000 @ 42.48 | View | ||
| 2025-02-27 | Karah Herdman Parschauer | Disposed 2990 @ 42.88 | View |
Monitoring Ultragenyx's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Ultragenyx's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Ultragenyx. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Ultragenyx's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Ultragenyx | Build AI portfolio with Ultragenyx Stock |
Ultragenyx's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Ultragenyx's future performance. Based on our forecasts, it is anticipated that Ultragenyx will maintain a workforce of about 1290 employees by March 2026.Ultragenyx Management Team Effectiveness
The company has return on total asset (ROA) of (0.2492) % which means that it has lost $0.2492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1343) %, meaning that it created substantial loss on money invested by shareholders. Ultragenyx's management efficiency ratios could be used to measure how well Ultragenyx manages its routine affairs as well as how well it operates its assets and liabilities. As of February 14, 2026, Return On Tangible Assets is expected to decline to -0.42. In addition to that, Return On Capital Employed is expected to decline to -0.44. At present, Ultragenyx's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 20.3 M, whereas Other Current Assets are forecasted to decline to about 36 M.As of February 14, 2026, Common Stock Shares Outstanding is expected to decline to about 58 M. The current year's Net Loss is expected to grow to about (604.8 M)The majority of Ultragenyx outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Ultragenyx to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Ultragenyx. Please pay attention to any change in the institutional holdings of Ultragenyx as this could imply that something significant has changed or is about to change at the company.
Shares in Circulation | First Issued 2012-12-31 | Previous Quarter 98.5 M | Current Value 99.9 M | Avarage Shares Outstanding 55.4 M | Quarterly Volatility 22 M |
Ultragenyx Workforce Comparison
Ultragenyx is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 3,633. Ultragenyx totals roughly 1,294 in number of employees claiming about 36% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.07. Ultragenyx Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ultragenyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ultragenyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Ultragenyx insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-06-01 | 4.6667 | 14 | 3 | 115,689 | 3,167 |
| 2025-03-01 | 1.5333 | 23 | 15 | 610,853 | 163,565 |
| 2024-09-01 | 0.25 | 1 | 4 | 700.00 | 40,675 |
| 2024-06-01 | 2.8 | 14 | 5 | 106,715 | 12,053 |
| 2024-03-01 | 1.5882 | 27 | 17 | 503,891 | 90,333 |
| 2023-12-01 | 1.0 | 5 | 5 | 309,566 | 205,462 |
| 2023-09-01 | 0.5 | 3 | 6 | 6,702 | 11,133 |
| 2023-06-01 | 1.0625 | 17 | 16 | 92,810 | 64,250 |
| 2023-03-01 | 1.6154 | 21 | 13 | 479,104 | 53,037 |
| 2022-06-01 | 12.5 | 25 | 2 | 134,720 | 427.00 |
| 2022-03-01 | 1.6 | 24 | 15 | 627,271 | 64,563 |
| 2021-09-01 | 0.3333 | 3 | 9 | 119,570 | 135,600 |
| 2021-06-01 | 1.125 | 18 | 16 | 61,540 | 46,194 |
| 2021-03-01 | 1.4 | 28 | 20 | 255,484 | 183,032 |
| 2020-12-01 | 0.3158 | 6 | 19 | 110,000 | 95,746 |
| 2020-09-01 | 0.4483 | 13 | 29 | 76,038 | 220,039 |
| 2020-06-01 | 0.4894 | 23 | 47 | 102,919 | 138,707 |
| 2020-03-01 | 2.6364 | 29 | 11 | 482,718 | 86,803 |
| 2019-12-01 | 9.0 | 9 | 1 | 14,050 | 1,297 |
| 2019-09-01 | 0.75 | 3 | 4 | 36,843 | 32,752 |
| 2019-06-01 | 1.0 | 26 | 26 | 92,343 | 58,861 |
| 2019-03-01 | 1.8 | 36 | 20 | 593,408 | 71,909 |
| 2018-12-01 | 0.75 | 3 | 4 | 102,000 | 30,000 |
| 2018-09-01 | 0.2857 | 2 | 7 | 8,350 | 29,449 |
| 2018-06-01 | 1.0417 | 25 | 24 | 81,619 | 50,525 |
| 2018-03-01 | 2.1111 | 19 | 9 | 463,288 | 14,555 |
| 2017-09-01 | 1.0 | 2 | 2 | 7,500 | 1,645 |
| 2017-06-01 | 1.1538 | 15 | 13 | 54,375 | 6,598 |
| 2017-03-01 | 3.6 | 18 | 5 | 268,725 | 50,500 |
| 2016-12-01 | 0.2083 | 5 | 24 | 50,500 | 134,500 |
| 2016-06-01 | 1.6842 | 32 | 19 | 365,050 | 46,310 |
| 2016-03-01 | 0.375 | 3 | 8 | 17,000 | 5,125 |
| 2015-12-01 | 0.0769 | 2 | 26 | 13,500 | 90,125 |
| 2015-09-01 | 0.3 | 6 | 20 | 222,500 | 48,318 |
| 2015-06-01 | 1.5 | 21 | 14 | 310,800 | 40,001 |
| 2015-03-01 | 0.3333 | 3 | 9 | 26,319 | 30,818 |
| 2014-12-01 | 0.1111 | 1 | 9 | 29,108 | 57,107 |
| 2014-09-01 | 0.8571 | 6 | 7 | 205,000 | 2,322,399 |
| 2014-03-01 | 0.7917 | 19 | 24 | 7,343,502 | 24,803,067 |
| 2007-09-01 | 1.0 | 6 | 6 | 59,487 | 59,487 |
| 2007-03-01 | 0.6471 | 11 | 17 | 115,567 | 137,147 |
| 2006-06-01 | 0.1667 | 2 | 12 | 20,000 | 40,000 |
| 2006-03-01 | 1.1818 | 13 | 11 | 176,463 | 77,090 |
| 2005-12-01 | 0.1538 | 2 | 13 | 25,569 | 53,138 |
| 2005-09-01 | 0.25 | 1 | 4 | 20,000 | 40,000 |
| 2005-06-01 | 0.2727 | 3 | 11 | 39,293 | 78,586 |
| 2005-03-01 | 1.2 | 6 | 5 | 98,762 | 60,000 |
| 2004-12-01 | 0.2 | 2 | 10 | 25,000 | 50,000 |
| 2004-09-01 | 0.7273 | 8 | 11 | 87,785 | 70,570 |
| 2004-06-01 | 0.2 | 1 | 5 | 10,000 | 25,000 |
| 2004-03-01 | 1.125 | 9 | 8 | 95,498 | 115,998 |
Ultragenyx Notable Stakeholders
An Ultragenyx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ultragenyx often face trade-offs trying to please all of them. Ultragenyx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ultragenyx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Erik Harris | Executive Vice President and Chief Commercial Officer | Profile | |
| Howard Horn | Executive CFO | Profile | |
| Dennis Huang | Chief Technical Operations Officer and Sr. VP | Profile | |
| Thomas Kassberg | Chief Bus. Officer and Sr. VP | Profile | |
| Joshua Higa | Director Communications | Profile | |
| Theodore Huizenga | Corporate VP | Profile | |
| Eric MD | Chief VP | Profile | |
| Arjun Natesan | Vice Research | Profile | |
| Vimal Srivastava | Senior Management | Profile | |
| Aaron Olsen | Senior Finance | Profile | |
| Paul JD | Vice Property | Profile | |
| Camille MD | Chief VP | Profile | |
| Erik MBA | Executive Officer | Profile | |
| Alison Skrinar | Vice Evaluation | Profile | |
| Danielle Keatley | Senior Communications | Profile | |
| Samuel Wadsworth | Chief Therapy | Profile | |
| Wenchi Liu | Corporate Counsel | Profile | |
| Ernie Meyer | Chief VP | Profile | |
| Karah JD | Chief Affairs | Profile | |
| John II | Chief Sciences | Profile |
About Ultragenyx Management Performance
The success or failure of an entity such as Ultragenyx often depends on how effective the management is. Ultragenyx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ultragenyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ultragenyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.42) | (0.44) | |
| Return On Assets | (0.34) | (0.36) | |
| Return On Equity | (2.56) | (2.44) |
Please note, the presentation of Ultragenyx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ultragenyx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ultragenyx's management manipulating its earnings.
Ultragenyx Workforce Analysis
Traditionally, organizations such as Ultragenyx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ultragenyx within its industry.Ultragenyx Manpower Efficiency
Return on Ultragenyx Manpower
| Revenue Per Employee | 520.1K | |
| Revenue Per Executive | 33.6M | |
| Net Loss Per Employee | 439.9K | |
| Net Loss Per Executive | 28.5M | |
| Working Capital Per Employee | 365.5K | |
| Working Capital Per Executive | 23.6M |
Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world |